Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Endocrine disorders – page 44

  • 520 clinical trials
  • 189 recruiting
  • 215 conditions
  • 25 countries

Conditions in this area

215 conditions with trials, the busiest first

Type 2 diabetes mellitus95Type 1 diabetes mellitus42Obesity29Endocrine ophthalmopathy27Neuroblastoma26Overweight22Diabetes mellitus21Neuroendocrine tumour19Gastroenteropancreatic neuroendocrine tumour disease16Diabetic retinal oedema15Diabetic foot13Diabetic neuropathy13Chronic kidney disease12Myotonic dystrophy12Adrenogenital syndrome11Graves' disease11Neuroendocrine carcinoma11Thyroid cancer11Hypoparathyroidism10Acromegaly8Adrenoleukodystrophy8Glucose tolerance impaired8Pancreatic neuroendocrine tumour7Adrenocortical carcinoma6+191

Clinical trials in Endocrine disorders

520 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

520 clinical trials

Neuroendocrine carcinoma metastatic

Not recruiting

Study of durvalumab, carboplatin and etoposide combination therapy for patients with metastatic large-cell neuroendocrine lung cancer who have not received previous treatment

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:G.O.I.R.C. Gruppo Oncologico Italiano Di Ricerca Clinica

Precocious puberty

Not recruiting

Study on Slowing Advanced Puberty in Girls Using Metformin, Pioglitazone, and Spironolactone

Investigational
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Metformin
  • Sponsor:Hospital Universitari De Girona Doctor Josep Trueta

Endocrine ophthalmopathy

Not recruiting

Study on the Safety and Tolerability of VRDN-001 for Patients with Thyroid Eye Disease

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-001
  • Sponsor:Viridian Therapeutics Inc.

Diabetic retinal oedema

Not recruiting

Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:EYE103
  • Sponsor:Eyebiotech Limited

Substances studied in this area

The therapies tested most often in Endocrine disorders trials.

Semaglutide52 clinical trialsDapagliflozin22 clinical trialsEmpagliflozin14 clinical trialsMetformin Hydrochloride13 clinical trialsSodium Chloride13 clinical trialsCisplatin11 clinical trialsEtoposide11 clinical trialsInsulin Glargine11 clinical trialsLutetium (177LU) oxodotreotide11 clinical trials
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.